TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 79 filers reported holding TRINITY BIOTECH PLC in Q2 2016. The put-call ratio across all filers is 3.53 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $1,291,000 | -5.9% | 230,145 | +0.7% | 0.00% | -50.0% |
| Q2 2017 | $1,372,000 | +0.8% | 228,609 | +0.1% | 0.00% | 0.0% |
| Q1 2017 | $1,361,000 | -13.9% | 228,391 | +0.0% | 0.00% | 0.0% |
| Q4 2016 | $1,580,000 | -53.2% | 228,373 | -10.6% | 0.00% | -60.0% |
| Q3 2016 | $3,376,000 | +16.6% | 255,360 | 0.0% | 0.01% | 0.0% |
| Q2 2016 | $2,896,000 | +3.6% | 255,360 | +6.5% | 0.01% | 0.0% |
| Q1 2016 | $2,795,000 | – | 239,700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACK Asset Management | 815,041 | $15,690,000 | 4.96% |
| Lyon Street Capital, LLC | 570,387 | $10,980,000 | 4.73% |
| Centaur Capital | 135,000 | $2,599,000 | 3.61% |
| GOLDMAN CAPITAL MANAGEMENT INC | 309,690 | $5,962,000 | 3.48% |
| Paradice Investment Management LLC | 584,024 | $11,242,000 | 2.36% |
| RK Capital | 601,672 | $11,582,000 | 2.31% |
| Park West Asset Management LLC | 673,079 | $12,957,000 | 1.89% |
| KEANE CAPITAL MANAGEMENT INC | 95,259 | $1,834,000 | 1.79% |
| Adirondack Research & Management Inc. | 227,052 | $4,371,000 | 1.70% |
| Benchmark Capital Advisors | 92,441 | $1,779,000 | 1.17% |